Clinical Trials
4 trialsNCT02253992 2020-10-05
An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma
Bristol-Myers Squibb
Phase 1/2 Terminated
NCT00309023 2015-10-12
Study of BMS-663513 in Patients With Advanced Cancer
Bristol-Myers Squibb
Phase 1/2 Terminated
NCT00351325 2009-09-04
A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies
Bristol-Myers Squibb
Phase 1 Terminated
NCT00461110 2009-09-04
A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC)
Bristol-Myers Squibb
Phase 1 Terminated